Aubert I, Cécyre D, Gauthier S, Quirion R
Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Douglas Hospital Research Center, Verdun, Quebec, Canada.
Eur J Pharmacol. 1992 Jul 7;217(2-3):173-84. doi: 10.1016/0014-2999(92)90843-s.
The novel radioligand [3H]AF-DX 384 binds specifically and saturably to putative muscarinic M2 receptor sites in homogenates of rat cerebral cortex. In saturation studies, [3H]AF-DX 384 appears to bind to two subpopulations of sites/states, one of high affinity (Kd1 = 0.28 +/- 0.08 nM) and another of low affinity (Kd2 = 28.0 +/- 5.0 nM). The maximal binding capacity (Bmax) of [3H]AF-DX 384 binding sites represented 9.7 +/- 2.3 fmol/mg protein (Bmax1) and 1993 +/- 551 fmol/mg protein (Bmax2) for the high and low affinity sites/states, respectively. The ligand selectivity profile of [3H]AF-DX 384 (at 2 nM) revealed that (-)-quinuclidinyl benzylate = atropine greater than 4-diphenylacetoxy-N-methylpiperidine methobromide greater than AQ-RA 741 greater than AF-DX 384 greater than UH-AH 371 much greater than methoctramine greater than oxotremorine-M greater than hexahydro-sila-defenidol much greater than pirenzepine greater than carbamylcholine much much greater than nicotine. This suggests that under our assay conditions [3H]AF-DX 384 binds mostly to M2-like muscarinic receptors in the rat central nervous system. This is further supported by the clear M2-like pattern of distribution observed using quantitative receptor autoradiography. High densities of specific labelling were seen in areas such as the hypoglossal nucleus, the pontine nucleus, the superior colliculus, the motor trigeminal nucleus, various thalamic nuclei and certain cortical laminae. Compared to [3H]AF-DX 116, the percentage of specific binding detected with [3H]AF-DX 384 was much higher. This is likely to be related to the greater chemical stability and affinity of [3H]AF-EX 384. In addition, autoradiograms obtained with [3H]AF-DX 384 (2 nM) are of better quality with film exposure periods five shorter than those needed for [3H]AF-DX 116 (10 nM). Therefore, [3H]AF-DX 384 displays a good selectivity for muscarinic M2 sites and offers major advantages, including higher affinity and greater stability, over previously used ligands.
新型放射性配体[3H]AF-DX 384能特异性且饱和地结合大鼠大脑皮层匀浆中假定的毒蕈碱M2受体位点。在饱和研究中,[3H]AF-DX 384似乎结合于两个亚群的位点/状态,一个具有高亲和力(Kd1 = 0.28±0.08 nM),另一个具有低亲和力(Kd2 = 28.0±5.0 nM)。[3H]AF-DX 384结合位点的最大结合容量(Bmax)对于高亲和力和低亲和力位点/状态分别为9.7±2.3 fmol/mg蛋白(Bmax1)和1993±551 fmol/mg蛋白(Bmax2)。[(3H]AF-DX 384(2 nM)的配体选择性谱显示,(-)-奎宁环基苄酯 = 阿托品>4-二苯基乙酰氧基-N-甲基哌啶甲溴化物>AQ-RA 741>AF-DX 384>UH-AH 371>甲奥克溴铵>氧震颤素-M>六氢硅代地芬尼多>哌仑西平>氨甲酰胆碱>>>烟碱。这表明在我们的测定条件下,[3H]AF-DX 384主要结合大鼠中枢神经系统中类似M2的毒蕈碱受体。使用定量受体放射自显影观察到的清晰的类似M2的分布模式进一步支持了这一点。在舌下神经核、脑桥核、上丘、运动三叉神经核、各种丘脑核和某些皮质层等区域观察到高密度的特异性标记。与[3H]AF-DX 116相比,用[3H]AF-DX 384检测到的特异性结合百分比要高得多。这可能与[3H]AF-EX 384更高的化学稳定性和亲和力有关。此外,用[3H]AF-DX 384(2 nM)获得的放射自显影片质量更好,胶片曝光时间比[3H]AF-DX 116(10 nM)所需的时间短五倍。因此,[3H]AF-DX 384对毒蕈碱M2位点显示出良好的选择性,并且与先前使用的配体相比具有主要优势,包括更高的亲和力和更大的稳定性。